Ixeris dentataNAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice
Open Access
- 8 September 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-9
- https://doi.org/10.1155/2013/671281
Abstract
Ixeris dentata (ID) is an herbal medicine used in Asian countries to treat indigestion, pneumonia, hepatitis, contusions, and tumors; however, its effect on intestinal inflammation is unknown. Thus, we investigated the effect of ID in the dextran sulfate sodium (DSS) model of colitis in female BALB/c mice; animals were evaluated after seven days of DSS treatment. DSS-treated mice showed considerable clinical signs, including weight loss, reduced colon length, colonic epithelial injury, infiltration of inflammatory cells in the colon tissue, and upregulation of inflammatory mediators. However, administration of ID attenuated body weight loss, colon shortening, and the increase in disease activity index score. ID also significantly decreased the colonic mucosal injury and the number of infiltrating mast cells. Moreover, ID inhibited the expressions of cyclooxygenase-2 and hypoxia-inducible factor-1α in colon tissue. Taken together, the results provide experimental evidence that ID might be a useful therapy for patients with ulcerative colitis.Keywords
Funding Information
- National Research Foundation of Republic of Korea (2012M2B2B1055244, 2011-0030717)
This publication has 42 references indexed in Scilit:
- The Beneficial Effect of Vanillic Acid on Ulcerative ColitisMolecules, 2010
- HIF-1α regulates epithelial inflammation by cell autonomous NFκB activation and paracrine stromal remodelingBlood, 2008
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase InhibitionGastroenterology, 2008
- Aggravation by Selective COX-1 and COX-2 Inhibitors of Dextran Sulfate Sodium (DSS)-Induced Colon Lesions in RatsDigestive Diseases and Sciences, 2007
- Current Therapy of Inflammatory Bowel Disease in ChildrenPediatric Drugs, 2006
- Biologic Therapy for Inflammatory Bowel DiseaseDrugs, 2005
- NS398 reduces hypoxia‐inducible factor (HIF)‐1α and HIF‐1 activity: Multiple‐level effects involving cyclooxygenase‐2 dependent and independent mechanismsInternational Journal of Cancer, 2004
- Ixeris dentata Extract Maintains Glutathione Concentrations in Mouse Brain Tissue Under Oxidative Stress Induced by Kainic AcidJournal of Medicinal Food, 2003
- Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel diseaseGut, 2001
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993